Skip to main content

Semnur Pharmaceuticals, Inc.

SMNRW
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001913577

No open-market purchases or sales by Semnur Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesSMNR

13F holders, Q1 2025

Institutional positions in Semnur Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
19
0 vs. Q4 2024
Shares held
6.16M
−44.5K (−0.7%) vs. Q4 2024
Total value
$319.8K
+$106.2K (+49.7%) vs. Q4 2024
New holders
0
0 more added
Sold out
0
1 more reduced

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SMNRW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 19 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 13 institutionsQ3 2022: 25 institutionsQ4 2022: 25 institutionsQ1 2023: 28 institutionsQ2 2023: 27 institutionsQ3 2023: 29 institutionsQ4 2023: 28 institutionsQ1 2024: 25 institutionsQ2 2024: 20 institutionsQ3 2024: 22 institutionsQ4 2024: 19 institutionsQ1 2025: 19 institutionsQ2 2025: 3 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2025: $319.8K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $440.0KQ3 2022: $486.1KQ4 2022: $244.2KQ1 2023: $421.2KQ2 2023: $381.8KQ3 2023: $435.8KQ4 2023: $321.3KQ1 2024: $279.6KQ2 2024: $107.8KQ3 2024: $343.3KQ4 2024: $213.6KQ1 2025: $319.8KQ2 2025: $59.8KQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding SMNRW and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20253$59.8K
Q1 202519$319.8K
Q4 202419$213.6K
Q3 202422$343.3K
Q2 202420$107.8K
Q1 202425$279.6K
Q4 202328$321.3K
Q3 202329$435.8K
Q2 202327$381.8K
Q1 202328$421.2K
Q4 202225$244.2K
Q3 202225$486.1K
Q2 202213$440.0K
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Semnur Pharmaceuticals, Inc.; share changes are against Q4 2024.

Institutions holding SMNRW in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Polar Asset Management Partners Inc.1,400,000$82.9K0.00%00.0%Unchanged
Context Capital Management, LLC605,000$35.8K0.00%00.0%Unchanged
Atw Spac Management LLC470,000$23.5K0.04%00.0%Unchanged
Cubist Systematic Strategies, LLC393,423$23.3K0.00%00.0%Unchanged
Saba Capital Management, L.P.410,000$20.5K0.00%00.0%Unchanged
Hudson Bay Capital Management LP312,957$18.5K0.00%00.0%Unchanged
Shaolin Capital Management LLC312,321$18.5K0.00%−44,490−12.5%Reduced
Calamos Advisors LLC350,000$17.6K0.00%00.0%Unchanged
Taconic Capital Advisors LP257,500$15.1K0.00%00.0%Unchanged
D. E. Shaw & Co., Inc.225,000$13.2K0.00%00.0%Unchanged
Whitebox Advisors LLC191,579$11.3K0.00%00.0%Unchanged
Wolverine Asset Management LLC162,419$9.62K0.00%00.0%Unchanged
Clear Street LLC132,600$7.85K0.00%00.0%Unchanged
Periscope Capital Inc.125,000$6.26K0.00%00.0%Unchanged
Rivernorth Capital Management, LLC154,800$6.25K0.00%00.0%Unchanged
Yakira Capital Management, Inc.95,000$4.76K0.00%00.0%Unchanged
Cable Car Capital LLC45,000$2.66K0.00%00.0%Unchanged
Glazer Capital, LLC49,088$2.00K0.00%00.0%Unchanged
Boothbay Fund Management, LLC470,000––00.0%Unchanged